Because oxidative stress leads to TRPM2-mediated cell death, in noncancerous cells TRPM2 is a therapeutic target in conditions such as inflammation, stroke, and diabetes due to the protective effects elicited following TRPM2 antagonism [38,39,40]. This evidence concerns the gene TRPM2 and stroke disorder.